Affordable and alternative versions of popular weigh loss drugs, like Ozempic and Wegovy, may no longer be available.
The trend of prescribing semaglutide to treat cardiovascular disease is expected to continue to grow. At the American College of Cardiology’s 74th Annual Scientific Session in Chicago, results were ...